Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: A clinical prospective study

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 461-471

  Brugiere O ^a,b,c,d,e   Thabut, G ^a,b,c,d   Krawice Radanne, I ^b,e   Rizzo, R ^f   Dauriat, G ^a,b,c   Danel, C ^a,b,c   Suberbielle, C ^e   Mal, H ^a,b,c,d   Stern, M ^g   Schilte, C ^b,d   Pretolani, M ^b,d   Carosella, E D ^b,e   Rouas Freiss, N ^b,e  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d DHU Fire   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY OF FERRARA   (Italy)

^g FOCH HOSPITAL   (France)

Author keywords

Bronchiolitis obliterans (BOS); clinical research practice; clinical trial; immune regulation; immunobiology; lung (allograft) function dysfunction; lung transplantation pulmonology; tolerance; translational research science

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIBODY; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; ALLOGRAFT; ANTIGEN EXPRESSION; ARTICLE; CHRONIC GRAFT REJECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CHEMISTRY; COHORT ANALYSIS; GRAFT REJECTION; KAPLAN MEIER METHOD; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR; TIME;

ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COHORT STUDIES; FEMALE; GRAFT REJECTION; HLA-G ANTIGENS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANT RECIPIENTS;

EID: 84921559068     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12977     Document Type: Article

References (44)

1. Kotloff RM, Thabut G., Lung transplantation.Am J Respir Crit Care Med 2011; 184: 159-171.
2. Girlanda R, Kirk AD., Frontiers in nephrology: Immune tolerance to allografts in humans.J Am Soc Nephrol 2007; 18: 2242-2251.
3. Loustau M, Wiendl H, Ferrone S, Carosella ED., HLA-G 2012 conference: The 15-year milestone update.Tissue Antigens 2013; 81: 127-136.
4. Carosella ED, Favier B, Rouas-Freiss N, Moreau P, LeMaoult J., Beyond the increasing complexity of the immunomodulatory HLA-G molecule.Blood 2008; 111: 4862-4870.
5. Hviid TVF., HLA-G in human reproduction: Aspects of genetics, function and pregnancy complications.Hum Reprod Update 2006; 12: 209-232.
6. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED., Implication of HLA-G molecule in heart-graft acceptance.Lancet 2000; 355: 2138.
7. Lila N, Amrein C, Guillemain R, et al.Human leukocyte antigen-g expression after heart transplantation is associated with a reduced incidence of rejection.Circulation 2002; 105: 1949-1954.
8. Creput C, Durrbach A, Menier C, et al.Human leukocyte antigen-g (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.J Hepatol 2003; 39: 587-594.
9. Creput C, Le Friec G, Bahri R, et al.Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for monitoring patients.Hum Immunol 2003; 64: 1033-1038.
10. Luque J, Torres MI, Aumente MD, et al.Soluble HLA-G in heart transplantation: Their relationship to rejection episodes and immunosuppressive therapy.Hum Immunol 2006; 67: 257-263.
11. Qiu J, Terasaki PI, Miller J, Mizutani K, Cai J, Carosella ED., Soluble HLA-G expression and renal graft acceptance.Am J Transplant 2006; 6: 2152-2156.
12. Crispim JC, Duarte RA, Soares CP, et al.Human leukocyte antigen-g expression after kidney transplantation is associated with a reduced incidence of rejection.Transpl Immunol 2008; 18: 361-367.
13. Sheshgiri R, Rouas-Freiss N, Rao V, et al.Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.J Heart Lung Transplant 2008; 27: 522-527.
14. Le Rond S, Azema C, Krawice-Radanne I, et al.Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells.J Immunol 2006; 176: 3266-3276.
15. Naji A, Le Rond S, Durrbach A, et al.CD3+ CD4low and CD3+ CD8low are induced by HLA-G: Novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.Blood 2007; 110: 3936-3948.
16. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED., HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.J Immunol 2001; 166: 5018-5026.
17. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED., Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism.Proc Natl Acad Sci U S A 2001; 98: 12150-12155.
18. Contini P, Ghio M, Poggi A, et al.Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.Eur J Immunol 2003; 33: 125-134.
19. Brugiere O, Thabut G, Pretolani M, et al.Immunohistochemical study of HLA-G expression in lung transplant recipients.Am J Transplant 2009; 9: 1427-1438.
20. Brugiere O, Thabut G, Mal H, et al.Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome.Eur Respir J 2005; 25: 813-819.
21. Stewart S, Fishbein MC, Snell GI, et al.Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.J Heart Lung Transplant 2007; 26: 1229-1242.
22. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R., Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection.J Immunol 2000; 164: 6426-6434.
23. Lafon M, Prehaud C, Megret F, et al.Modulation of HLA-G expression in human neural cells after neurotropic viral infections.J Virol 2005; 79: 15226-15237.
24. LeBouder F, Khoufache K, Menier C, et al.Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection.Hum Immunol 2009; 70: 1016-1019.
25. Swarup R, Allenspach LL, Nemeh HW, Stagner LD, Betensley AD., Timing of basiliximab induction and development of acute rejection in lung transplant patients.J Heart Lung Transplant 2011; 30: 1228-1235.
26. Cooper JD, Billingham M, Egan T, et al.A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts.J Heart Lung Transplant 1993; 12: 713-721.
27. Verleden GM, Vos R, Verleden SE, et al.Survival determinants in lung transplant patients with chronic allograft dysfunction.Transplantation 2011; 92: 703-708.
28. Rizzo R, Farina I, Bortolotti D, et al.HLA-G may predict the disease course in patients with early rheumatoid arthritis.Hum Immunol 2013; 74: 425-432.
29. Kennedy VE, Todd JL, Palmer SM., Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.Am J Transplant 2013; 13: 552-561.
30. Bukur J, Rebmann V, Grosse-Wilde H, et al.Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.Cancer Res 2003; 63: 4107-4111.
31. Wiendl H, Mitsdoerffer M, Hofmeister V, et al.A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape.J Immunol 2002; 168: 4772-4780.
32. Paul P, Rouas-Freiss N, Khalil-Daher I, et al.HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance.Proc Natl Acad Sci U S A 1998; 95: 4510-4515.
33. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED., HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism ? Cancer Res 2005; 65: 10139-10144.
34. Torres MI, Le Discorde M, Lorite P, et al.Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease.Int Immunol 2004; 16: 579-583.
35. Lila N, Amrein C, Guillemain R, Chevalier P, Fabiani JN, Carpentier A., Soluble human leukocyte antigen-G: A new strategy for monitoring acute and chronic rejection after lung transplantation.J Heart Lung Transplant 2007; 26: 421-422.
36. Nicodemus-Johnson J, Laxman B, Stern RK, et al.Maternal asthma and microRNA regulation of soluble HLA-G in the airway.J Allergy Clin Immunol 2013; 131: 1496-1503.
37. + T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients.Eur J Immunol 2004; 34: 649-660.
38. Moreau P, Adrian-Cabestre F, Menier C, et al.IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes.Int Immunol 1999; 11: 803-811.
39. Kanai T, Fujii T, Kozuma S, et al.Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture.Mol Hum Reprod 2001; 7: 195-200.
40. Sheshgiri R, Rao V, Mociornita A, Ross HJ, Delgado DH., Association between HLA-G expression and C4d staining in cardiac transplantation.Transplantation 2010; 89: 480-481.
41. Naji A, Menier C, Morandi F, et al.Binding of HLA-G to ITIM-bearing Ig-like receptors suppresses B cell responses.J.Immunol 2014; 15: 1536-1546.
42. Elssner A, Jaumann F, Dobmann S, et al.Munich Lung Transplant Group.Elevated levels of interleukine-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans sybdrome: Proinflammatory role of bronchial epithelial cells.Transplantation 2000; 70: 362-367.
43. White SR, Loisel DA, Stern R, Laxman B, Floreth T, Marroquin BA., Human leukocyte antigen-G expression in differentiated human airway epithelial cells: Lack of modulation by Th2-associated cytokines.Respir Res 2013; 14: 4.
44. Kumar D, Husain S, Hong Chen M, et al.Prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.Transplantation 2010; 89: 1028-1033.